Cefotaxime sodium NEW
| Price | $46 | $113 |
| Package | 100mg | 500mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-06-19 |
Product Details
| Product Name: Cefotaxime sodium | CAS No.: 64485-93-4 |
| Purity: 99.52% | Supply Ability: 10g |
| Release date: 2025/06/19 |
Product Introduction
Bioactivity
| Name | Cefotaxime sodium |
| Description | Cefotaxime is a third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram positive and Gram negative bacteria. In most cases, it is considered to be equivalent to ceftriaxone in terms of safety and efficacy. Cefotaxime sodium (Cefotaxim sodium salt) is marketed under various trade names including Claforan (Sanofi-Aventis). |
| In vitro | It has activity in presence of some beta-lactamases, both penicillinases and cephalosporinases of Gram negative and Gram positive bacteria. Its spectrum of activity includes most strains of bacterial pathogens responsible for septicaemia, respiratory tract infections, urinary tract infections, soft tissue infections, bone and joint infections, obstetric and gynaecological infections, and other various types of infections[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO : 50 mg/mL (104.73 mM), Sonication is recommended. Ethanol : < 1 mg/mL (insoluble or slightly soluble) |
| Keywords | PBPs | Inhibitor | inhibit | HR-756 | HR756 | HR 756 | Cefotaxime sodium | Cefotaxime | Cefotaxim sodium | Cefotaxim | Bacterial | Antibiotic |
| Inhibitors Related | Neomycin sulfate | Dehydroacetic acid sodium | Ampicillin sodium | Methyl anthranilate | Doxycycline (hyclate) | Kanamycin sulfate | Urethane | Sulfamethoxazole sodium | Doxycycline | EDTA copper(II) disodium salt | Isoeugenol | Dimethyl sulfoxide |
| Related Compound Libraries | FDA-Approved & Pharmacopeia Drug Library | Bioactive Compound Library | Approved Drug Library | ReFRAME Related Library | Drug-induced Liver Injury (DILI) Compound Library | Drug Repurposing Compound Library | FDA-Approved Drug Library | Immunology/Inflammation Compound Library | Clinical Compound Library | Bioactive Compounds Library Max | Covalent Inhibitor Library | Anti-COVID-19 Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $46.00/100mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2025-06-19 | |
| $46.00/100mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2025-04-27 | |
| $150.00/1kg |
VIP1Y
|
Hebei Zhuanglai Chemical Trading Co Ltd
|
2024-12-04 | |
| $1.00/1kg |
VIP7Y
|
Hebei Chuanghai Biotechnology Co., Ltd
|
2024-11-11 | |
| $100.00/1KG |
VIP5Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-09 | |
| $0.00/1kg |
VIP4Y
|
Sinoway Industrial co., ltd.
|
2024-08-06 | |
| $6.00/1kg |
VIP1Y
|
HebeiShuoshengImportandExportco.,Ltd
|
2024-08-02 | |
| $6.00/1kg |
Hebei Longbang Technology Co., Ltd
|
2024-05-23 | ||
| $6.00/1KG |
Hebei Saisier Technology Co., LTD
|
2024-04-25 | ||
| $0.00/5kg |
Henan Suikang Pharmaceutical Co.,Ltd.
|
2024-04-24 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY